CI & Patent News: 14/12/2010


1) Paragraph IV litigations

Cephalon, Inc. Vs Apotex, Inc (Product: may be Armodafinil )

Complaint filed at Delaware District Court on December 14, 2010

2) Meda acquires three OTC products from Glaxo in the US (Business wire); Product information is not disclosed. Glaxo markets totally five OTC product (TAGAMET HB; ABREVA; NICORETTE; COMMIT; ALLI) in US.

3) Reckitt Benckiser to buy India’s Paras for $726 mn (ET)

4) Inspire Announces Launch of DIQUASTM Ophthalmic Solution 3% (diquafosol tetrasodium) by Santen in Japan (Yahoo finance)

5) New dosing recommandation for Darunavir is approved by FDA (J&J Press release);  Ritonavir is HIV protease inhibitor and also CYP3A4 (a metabolic enzyme); This reduces metabolic clearance of other agent administered with ritonavir . We aware of approved combination of Lopinavir and Ritonavir.

6) USPTO Implements Pilot Program Extending Provisional Application Period (Patent Docs) (USPTO)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s